Armes Joseph B 4
4 · CSW INDUSTRIALS, INC. · Filed Dec 16, 2025
Insider Transaction Report
Form 4
Armes Joseph B
DirectorChairman, President & CEO
Transactions
- Sale
Common Stock
2025-12-15$317.40/sh−1,000$317,400→ 64,493 total - Gift
Common Stock
2025-12-16−967→ 63,526 total
Holdings
- 3,219(indirect: by ESOP)
Common Stock
- 8,004
Performance Rights
→ Common Stock (8,004 underlying) - 8,236
Performance Rights
→ Common Stock (8,236 underlying) - 12,422
Performance Rights
→ Common Stock (12,422 underlying) - 18,372
Performance Rights
→ Common Stock (18,372 underlying) - 19,685
Restricted Stock Units
→ Common Stock (19,685 underlying)
Footnotes (8)
- [F1]The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 12, 2024.
- [F2]The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $315.57 to $321.68, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Represents shares that were transferred by bona fide gift to the Armes Family Foundation, a family charitable foundation in which the reporting person has no pecuniary interest. Following the gift, the reporting person disclaims beneficial ownership of the securities held by the foundation.
- [F4]Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2025, and ending on March 31, 2028, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- [F5]Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024, and ending on March 31, 2027, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- [F6]Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023, and ending on March 31, 2026, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- [F7]Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in three equal amounts, at a rate between 0% and 200%, during three performance cycles ending on each of March 31, 2026 and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- [F8]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vest upon the successful first employment anniversary of a successor Chief Executive Officer.